Table V.
Progression free survival – clinical parameters’ influence in reTURB or non-reTURB groups
| Parameter | All Log-rank p | reTURB group Log-rank p | Non-reTURB group Log-rank p | Cox HR (95% CI)/p Multivariate |
|---|---|---|---|---|
| Gender (F/M) | 0.826 | 0.682 | 0.969 | n.s. |
| Ta/T1 | 0.145 | 0.059 | 0.055 | n.s. |
| HG/LG | 0.013 | 0.087 | < 0.001 | 1.95 (1.17–3.25)/0.010 |
| Muscle in primary TURB specimen, no/yes | 0.467 | 0.783 | 0.601 | n.s. |
| lamina propria focal/massive infiltration (T1) | 0.031 | 0.047 | 0.213 | n.s. |
| Concomitant CIS, no/yes | 0.015 | 0.695 | 0.011 | n.s. |
| EORTC risk group (intermediate/high) | 0.713 | – | 0.713 | n.s. |
| Focality (solitary/multiple) | 0.096 | 0.095 | 0.333 | n.s. |
| Primary recurrent | 0.462 | 0.751 | 0.925 | n.s. |
| Size (< 3 cm/> 3 cm) | 0.920 | 0.371 | 0.508 | n.s. |
| reTURB, no/yes | 0.031 | – | – | 1.94 (1.2–3.13)/0.007 |
F – female, M – male, TURB – transurethral resection of bladder tumour, CIS – carcinoma in situ, HR – hazard ratio, 95% CI – 95% confidence interval, the value of adjusted p < 0.05 was considered statistically significant (bolded), HR > 1 better outcome when reTURB performed, HR < 1 worse outcome when reTURB performed.